|
1H-Thieno[3,4-d]imidazole-4-pentanamide, N,N'-[1,2-ethanediylbis(oxy-2,1-ethanediyl)]bis[hexahydro-2-oxo-, [3aS-[3aα,4β(3aR*,4R*,6aS*),6aα]]- (9CI) Suppliers list
|
|
| | 1H-Thieno[3,4-d]imidazole-4-pentanamide, N,N'-[1,2-ethanediylbis(oxy-2,1-ethanediyl)]bis[hexahydro-2-oxo-, [3aS-[3aα,4β(3aR*,4R*,6aS*),6aα]]- (9CI) Basic information |
| Product Name: | 1H-Thieno[3,4-d]imidazole-4-pentanamide, N,N'-[1,2-ethanediylbis(oxy-2,1-ethanediyl)]bis[hexahydro-2-oxo-, [3aS-[3aα,4β(3aR*,4R*,6aS*),6aα]]- (9CI) | | Synonyms: | 1H-Thieno[3,4-d]imidazole-4-pentanamide, N,N'-[1,2-ethanediylbis(oxy-2,1-ethanediyl)]bis[hexahydro-2-oxo-, [3aS-[3aα,4β(3aR*,4R*,6aS*),6aα]]- (9CI);5-[(3aS,4S,6aR)-2-oxo-hexahydro-1H-thieno[3,4-d]imidazol-4-yl]-N-{2-[2-(2-{5-[(3aS,4S,6aR)-2-oxo-hexahydro-1H-thieno[3,4-d]imidazol-4-yl]pentanamido}ethoxy)ethoxy]ethyl}pentanamide;N,N'-((ethane-1,2-diylbis(oxy))bis(ethane-2,1-diyl))bis(5-((3aR,6S,6aS)-2-hydroxy-3a,4,6,6a-tetrahydro-1H-thieno[3,4-d]imidazol-6-yl)pentanimidic acid) | | CAS: | 194920-55-3 | | MF: | C26H44N6O6S2 | | MW: | 600.8 | | EINECS: | | | Product Categories: | | | Mol File: | 194920-55-3.mol | ![1H-Thieno[3,4-d]imidazole-4-pentanamide, N,N'-[1,2-ethanediylbis(oxy-2,1-ethanediyl)]bis[hexahydro-2-oxo-, [3aS-[3aα,4β(3aR*,4R*,6aS*),6aα]]- (9CI) Structure](CAS/20210305/GIF/194920-55-3.gif) |
| | 1H-Thieno[3,4-d]imidazole-4-pentanamide, N,N'-[1,2-ethanediylbis(oxy-2,1-ethanediyl)]bis[hexahydro-2-oxo-, [3aS-[3aα,4β(3aR*,4R*,6aS*),6aα]]- (9CI) Chemical Properties |
| Boiling point | 1004.0±65.0 °C(Predicted) | | density | 1.222±0.06 g/cm3(Predicted) | | pka | 13.60±0.40(Predicted) | | form | Solid | | color | Off-white to light yellow |
| | 1H-Thieno[3,4-d]imidazole-4-pentanamide, N,N'-[1,2-ethanediylbis(oxy-2,1-ethanediyl)]bis[hexahydro-2-oxo-, [3aS-[3aα,4β(3aR*,4R*,6aS*),6aα]]- (9CI) Usage And Synthesis |
| Uses | Biotin-PEG-Biotin is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1]. | | References | [1] An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562. DOI:10.1016/j.ebiom.2018.09.005 |
| | 1H-Thieno[3,4-d]imidazole-4-pentanamide, N,N'-[1,2-ethanediylbis(oxy-2,1-ethanediyl)]bis[hexahydro-2-oxo-, [3aS-[3aα,4β(3aR*,4R*,6aS*),6aα]]- (9CI) Preparation Products And Raw materials |
|